The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The receptors for LDL (LDLR) and transferrin receptor (TFR) are both endocytosed from the cell surface via clathrin-coated vesicles and transported through intracellular recycling pathways (14, 15, 16, 17, 18, 19, 20).”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Elevated LDL-C levels are linked to an increased risk of ASCVD,4,5”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [5]
In the citing paper
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
In the citing paper
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“Mutations in LDLR cause familial hypercholesterolemia (FH), characterized by elevated levels of plasma LDL-C and increased risk of coronary heart disease (1).”
From Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor (2022) · cites this paper as [1]
In the citing paper
“Statins block cholesterol synthesis by suppressing HMG-CoA reductase91”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citation
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Anitschkow, 1913, Ueber experimentelle cholesterinsteatose und ihre bedeutung für die entstehung einiger pathologischer prozesse, Zentralbl. Allg. Pathol. Anat., 24, 1
- Goldstein, 1982, Lipoprotein receptors: Genetic defense against atherosclerosis, Clin. Res., 30, 417
Cited by
Sorted by citations
Items 401–500 of 1,000
van Loon, N. M., Lindholm, D., & Zelcer, N. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000593 · Cited by 25
Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA
Sato, K., Takayama, K., Hashimoto, M., & Inoue, S. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.721579 · Cited by 24
Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players
Pfrieger, F. W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766587 · Cited by 22
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
Inasu, M., Feldt, M., Jernström, H., Borgquist, S., & Harborg, S. (2022) · The Breast · doi:10.1016/j.breast.2022.01.003 · Cited by 23
Zong, Q., Qu, H., Zhao, Y., Liu, H., Wu, S., Wang, S., Bao, W., & Cai, D. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00793-1 · Cited by 23
Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene
Bea, A. M., Lamíquiz-Moneo, I., Marco-Benedí, V., Mateo‐Gállego, R., Pérez‐Calahorra, S., Jarauta, E., Martín, C., Cenarro, A., & Civeira, F. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.01.024 · Cited by 24
Endocytic Adaptors in Cardiovascular Disease
Cui, K., Dong, Y., Wang, B., Cowan, D. B., Chan, S.-L., Shyy, J., & Chen, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624159 · Cited by 23
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Raccosta, L., Fontana, R., Corna, G., Maggioni, D., Moresco, M. A., & Russo, V. E. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1779-0 · Cited by 23
Bai, X., Zhang, J., Chang, Y., Gu, W., Lei, R., Qin, Y., Xia, S., Ma, S., Liang, Y., Chen, K., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092790 · Cited by 22
Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab
Xu, Q., Deng, Y., Xiao, J. H., Liu, X., Zhou, M., Ren, Z., Peng, J., Tang, Y., Jiang, Z., Tang, Z., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200505091738 · Cited by 23
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies
Dvela‐Levitt, M., Shaw, J. L., & Greka, A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.11.008 · Cited by 21
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer
O’Neill, K. I., Kuo, L., Williams, M. M., Lind, H., Crump, L. S., Hammond, N. G., Spoelstra, N. S., Caino, M. C., & Richer, J. K. (2022) · Cancers · doi:10.3390/cancers14143543 · Cited by 22
Zheng, C., Lin, Y., Jiang, B., Zhu, X., Lin, Q., Luo, W., Tang, M., & Xie, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.954453 · Cited by 21
Shin, S., Yang, E. H., Lee, H. C., Moon, S. H., & Ryoo, J. (2022) · BMC Public Health · doi:10.1186/s12889-022-14319-x · Cited by 22
Atherogenic modification of low-density lipoproteins
Sukhorukov, V. N., Карагодин, В. П., & Orekhov, A. N. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166204391 · Cited by 22
Albuquerque, E. L., Fulco, U. L., Caetano, E. W. S., & Freire, V. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108774956.011 · Cited by 21
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype
Sanin, V., Pfetsch, V., & Köenig, W. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0869-3 · Cited by 24
Li, M., Zhu, J., Wu, Q. H., & Wang, Q. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124876 · Cited by 22
Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol
Newman, C. B., & Tobert, J. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac708 · Cited by 20
Ijaz, A., Yarlagadda, B. R. G., & Orecchioni, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1589629 · Cited by 26
Preclinical toxicology profile of squalene epoxidase inhibitors
Nagaraja, R., Olaharski, A. J., Narayanaswamy, R., Mahoney, C. E., Pirman, D. A., Größ, S., Roddy, T. P., Popovici-Müller, J. V., Smolen, G. A., & Silverman, L. R. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115103 · Cited by 21
Hepatic distribution and toxicity of zirconia nanoparticles in vivo and in vitro
Sun, T., Liu, X., Zhan, X., Ou, L., & Lai, R. (2020) · Process Safety and Environmental Protection · doi:10.1016/j.psep.2020.09.021 · Cited by 21
Pineda-Lozano, J. E., Moreno, A. G. M., & Carrillo, C. A. V. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.637183 · Cited by 21
Sphingosine kinases regulate ER contacts with late endocytic organelles and cholesterol trafficking
Palladino, E. N. D., Bernaś, T., Green, C. D., Weigel, C., Singh, S. K., Senkal, C. E., Martello, A., Kennelly, J. P., Bieberich, E., Tontonoz, P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204396119 · Cited by 23
Ding, S., Wang, P., Pang, X., Zhang, L., Qian, L., Jia, X., Chen, W., Ruan, S., & Sun, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.958329 · Cited by 21
The potential role of statins in treating liver disease
Imprialos, K. P., Stavropoulos, K., Doumas, M. N., Skalkou, A., Zografou, I., & Athyros, V. G. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1439379 · Cited by 21
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience
Aljenedil, S., Alothman, L., Bélanger, A. M., Brown, L., Lahijanian, Z., Bergeron, J., Couture, P., Baass, A. W., Ruel, I. L., Brisson, D., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.028 · Cited by 21
Khan, T. G., Ginsburg, D., & Emmer, B. T. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100248 · Cited by 21
Alaseem, A. M., Alasiri, G. A., Ali, A. B. H., Hamdy, A. K., & El‐Wekil, M. M. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126620 · Cited by 20
Park, J., Kwon, O., Cho, S. Y., Paick, J., & Kim, S. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172751 · Cited by 20
Wang, C., Zou, Y., Pan, C., Shao, L., Ding, Z., Zhang, Y., Ye, J., Li, P., Ren, Y., & Zhu, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-1604 · Cited by 20
Rigon, L., Filippis, C. D., Napoli, B., Tomanin, R., & Orso, G. (2021) · Biomedicines · doi:10.3390/biomedicines9030268 · Cited by 21
Regulation of Plasma Membrane Sterol Homeostasis by Nonvesicular Lipid Transport
Koh, D. H. Z., & Saheki, Y. (2021) · Contact · doi:10.1177/25152564211042451 · Cited by 22
Girik, V., Feng, S., Hariri, H. H., Henne, W. M., & Riezman, H. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00120 · Cited by 20
Ferroptosis-targeting drugs in breast cancer
Zhang, S., Guo, L., Tao, R., & Liu, S. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2399181 · Cited by 23
Jun, D., Schumacher, M. M., Hwang, S., Kinch, L. N., Grishin, N. V., & DeBose‐Boyd, R. A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000551 · Cited by 20
Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats
Du, H., Li, C., Wang, Z., He, Y. T., Wang, Y., Zhou, H., Wan, H., & Yang, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114058 · Cited by 20
Lee, B. W., Kumar, V. B., Biswas, P., Ko, A. C., Alameddine, R. M., Granet, D. B., Ayyagari, R., Kikkawa, D. O., & Korn, B. S. (2018) · The Open Ophthalmology Journal · doi:10.2174/1874364101812010041 · Cited by 20
The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis
Chuan, J., Qian, Z., Zhang, Y., Tong, R., & Peng, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1036-1 · Cited by 19
Lee, Y. Y., Ha, J., Kim, Y. S., Ramani, S., Sung, S., Gil, E. S., Choo, O., Jang, J. H., & Choung, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417513 · Cited by 21
Yılmaz, H., & Bayraktutan, U. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040232 · Cited by 20
Zorn, S., Bounds, R., Williamson, A., Lawler, K., Hanßen, R., Keogh, J. M., Henning, E., Smith, M., Fielding, B. A., Umpleby, A. M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03976-1 · Cited by 19
Drugs associated with cataract formation represent an unmet need in cataract research
Carlson, J. O., McBride, K. A., & O’Connor, M. D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.947659 · Cited by 19
Svendsen, K., Olsén, T., Vinknes, K. J., Mundal, L. J., Holven, K. B., Bogsrud, M. P., Leren, T. P., Igland, J., & Retterstøl, K. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.015 · Cited by 18
A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking
Jeiran, K., Gordon, S. M., Sviridov, D. O., Aponte, A. M., Haymond, A. N., Piszczek, G., Lucero, D., Neufeld, E. B., Vaisman, I. I., Liotta, L. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911480 · Cited by 19
The natural history of phytosterolemia: Observations on its homeostasis
Mymin, D., Salen, G., Triggs‐Raine, B. L., Waggoner, D., Dembinski, T. C., & Hatch, G. M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.024 · Cited by 19
Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake
Galvan, A. M., & Chorba, J. S. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m087189 · Cited by 18
Li, H., Li, J., Zhang, X., Li, J., Xi, C., Wang, W.-Q., Lu, Y., & Xuan, L. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0274-0 · Cited by 19
Pagano, S., Magenta, A., D'Agostino, M., Martino, F., Barillà, F., Satta, N., Frias, M. A., Ronca, A., Mach, F., Gencer, B., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122035 · Cited by 22
Emerging roles of absent in melanoma 2 in cardiovascular diseases
Zhan-zhi, Z., Zheng, X., & Jiang, Z. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.031 · Cited by 20
Strong association of glaucoma with atherosclerosis
Song, X., Li, P., Li, Y., Yan, X., Yuan, L., Zhao, C., An, Y., & Chang, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-88322-4 · Cited by 19
Hepatic miR-378 modulates serum cholesterol levels by regulating hepatic bile acid synthesis
Sun, C., Liu, W., Lu, Z., Li, Y., Liu, S., Tang, Z., Yan, Y., Li, Z., Feng, H., Zhang, D., et al. (2021) · Theranostics · doi:10.7150/thno.53624 · Cited by 19
Sharma, H., Yadav, V., D’Souza‐Schorey, C., Go, D. B., Senapati, S., & Chang, H. (2023) · ACS Nano · doi:10.1021/acsnano.3c01340 · Cited by 18
He, J.-H., Li, S., Li, C., Li, K., Xu, Y., Wang, M., Zhao, S.-L., Zhang, J.-F., Zhong, X., Li, X., et al. (2023) · AIChE Journal · doi:10.1002/aic.18153 · Cited by 15
Sun, D., Luo, G., Zhang, Q., Wang, M., Yang, T., Wang, Y., & Pang, J. (2023) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2023.105646 · Cited by 18
La, R., Yin, Y., Ding, W., He, Z., Lu, L., Xu, B., Jiang, D., Huang, L., Jiang, J. C., Zhou, L., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02154-5 · Cited by 18
Genetic Markers for Coronary Artery Disease
Veljković, N., Zarić, B. L., Đorić, I., Obradovic, M. M., Sudar-Milovanovic, E. M., Radak, D. J., & Isenović, E. R. (2018) · Medicina · doi:10.3390/medicina54030036 · Cited by 18
LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease
Emanuelsson, F., & Benn, M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa242 · Cited by 18
Macchi, C., Bonalume, V., Greco, M. F., Mozzo, M., Melfi, V., Sirtori, C. R., Magnaghi, V., Corsini, A., & Ruscica, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105415 · Cited by 18
Chapman, M. J., Orsoni, A., Robillard, P., Thérond, P., & Giral, P. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.02.001 · Cited by 18
Maximizing the benefits of cholesterol-lowering drugs
Feingold, K. R. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000631 · Cited by 18
Squalene and cholesterol in the balance at the ER membrane
Nathan, J. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003388117 · Cited by 18
Cholesterol sensing and metabolic adaptation in tissue immunity
Dang, E. V., & Reboldi, A. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.09.013 · Cited by 17
Yi, C., Huynh, K., Schooneveldt, Y. L., Olshansky, G., Liang, A., Wang, T., Beyene, H. B., Dakic, A., Wu, J. Q., Cinel, M. A., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100800 · Cited by 17
Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia
Wang, Y., Spolitu, S., Zadroga, J. A., Sarecha, A. K., & Özcan, L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111259 · Cited by 17
The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases
Xie, J., Chen, X., Zheng, M., Zhu, J., & Mao, H. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904143 · Cited by 18
Tarugi, P., Bertolini, S., Calandra, S., Arca, M., Angelico, F., Casula, M., Cefalu, A. B., D’Erasmo, L., Fortunato, G., Filardi, P. P., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.05.002 · Cited by 18
Effective low-density lipoprotein-lowering therapy: Implementation in clinical practice
Sinning, D., & Landmesser, U. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317708349 · Cited by 18
The Interplay Between Cholesterol Metabolism and Intrinsic Ageing
Auley, M. T. M. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_4 · Cited by 18
Wu, S., & Näär, A. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215022 · Cited by 17
Hsu, W., Lai, C.-W., Chen, S., Chiou, H.-Y. C., Hsiao, P., Shin, S., & Lee, M. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0002 · Cited by 17
Shyamala, N., Gundapaneni, K. K., Galimudi, R. K., Tupurani, M. A., Padala, C., Puranam, K., Kupsal, K., Kummari, R., Gantala, S. R., Nallamala, K. R., et al. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3346 · Cited by 17
Incremental Value of Blood-Based Markers of Liver Fibrosis in Cardiovascular Risk Stratification
Georgiopoulos, G. A., Athanasopoulos, S., Mavraganis, G., Konstantaki, C., Papaioannou, M., Delialis, D., Angelidakis, L., Sachse, M., Papoutsis, D., Cavlan, B., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae619 · Cited by 16
Lipid metabolic reprogramming in immune regulation and chronic inflammatory diseases
Ito, A. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej25-0180 · Cited by 18
Zhang, Y., Li, F., Liu, L., An, Z., Luo, H., Zhang, H., Ma, R., Zhang, R., Dai, Q., Zhang, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202504990 · Cited by 19
Zhili, G., Zhimin, G., & Zhang, N. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1624225 · Cited by 18
Yu, Q., Zheng, H., & Zhang, Y. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106878 · Cited by 16
Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9
Bourbiaux, K., Legrand, B., Verdié, P., Mallart, S., Manette, G., Minoletti, C., Stepp, J. D., Prigent, P., Bail, J.-C. L., Gauzy, L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02051 · Cited by 17
Sarkar, P., Kumar, G. A., Shrivastava, S. K., & Chattopadhyay, A. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100206 · Cited by 16
Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Suresh, S., Rabbie, R., Garg, M., Lumaquin, D., Huang, T. H., Montal, E. D., Ma, Y., Cruz, N. M., Tang, X., Nsengimana, J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0427 · Cited by 17
Ahmad, P., Alvi, S. S., Iqbal, J., & Khan, M. S. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00330-1 · Cited by 19
Mäkinen, V., Kettunen, J., Lehtimäki, T. J., Kähönen, M. A. P., Viikari, J. S. A., Perola, M., Salomaa, V. V., Järvelin, M., Raitakari, O. T., & Ala‐Korpela, M. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01281-w · Cited by 16
Hong, S., Han, K., Park, J. H., Yu, S. H., Lee, C. B., & Kim, D. S. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.2.164 · Cited by 17
Sterols in Inflammatory Diseases: Implications and Clinical Utility
Yalçınkaya, A. S., Öztaş, Y., & Sabuncuoğlu, S. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-43883-7_13 · Cited by 17
Yoon, Y., Chung, K., Lee, S., Heo, S.-W., Kim, Y.-R., Lee, J. K., Kim, H.-J., Park, S., Shin, Y., & Lee, K. (2024) · Food & Function · doi:10.1039/d4fo00759j · Cited by 16
Zhang, Y., Kong, X., Liang, L., & Xu, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1365422 · Cited by 16
Lipid metabolism in myeloid cell function and chronic inflammatory diseases
Ito, A., & Suganami, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1495853 · Cited by 19
Rantanen, K. K., Strandberg, A. Y., Salomaa, V. V., Pitkälä, K. H., Tilvis, R. S., Tienari, P. J., & Strandberg, T. E. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1290821 · Cited by 16
Small dense and desialylated low density lipoprotein in diabetic patients
Sobenin, I. A., Валерьевна, Г. Е., Grechko, A. V., & Orekhov, A. N. (2017) · Vessel Plus · doi:10.20517/2574-1209.2016.12 · Cited by 16
Doonan, L. M., Fisher, E. A. A., & Brodsky, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.010 · Cited by 17
CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
Kjellmo, C. A., Hovland, A., & Lappegård, K. T. (2018) · Diseases · doi:10.3390/diseases6020045 · Cited by 16
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
Dubińska–Magiera, M., Migocka-Patrzałek, M., Lewandowski, D., Daczewska, M., & Jagla, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115654 · Cited by 17
Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist’s Perspective
Jurcău, A., & Simion, A. (2021) · Medicina · doi:10.3390/medicina57060616 · Cited by 16
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase
Sachdev, V., Duta-Mare, M., Korbelius, M., Vujić, N., Leopold, C., de Boer, J. F., Rainer, S., Fickert, P., Kolb, D., Kuipers, F., et al. (2021) · Cells · doi:10.3390/cells10102619 · Cited by 16
Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Cheng, C., Guo, J. Y., Geng, F., Wu, X., Cheng, X., Li, Q., & Guo, D. (2016) · Journal of Visualized Experiments · doi:10.3791/54709 · Cited by 16
Ofori‐Asenso, R., Zoungas, S., Tonkin, A. M., & Liew, D. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1125 · Cited by 16
Brown, R. B. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.020 · Cited by 18
Structure and mechanism of vitamin-K-dependent γ-glutamyl carboxylase
Wang, R., Chen, B., Elghobashi‐Meinhardt, N., Tie, J., Ayala, A., Zhou, N., & Qi, X. (2025) · Nature · doi:10.1038/s41586-024-08484-9 · Cited by 15
Protein restriction reprograms the multi-organ proteomic landscape of mouse aging
Lu, T., Xie, Y., Wang, Y., Lin, X., Cai, X., Zhang, Y., Nie, Z., Su, C., Gou, W., Zhang, H., et al. (2025) · Cell · doi:10.1016/j.cell.2025.10.004 · Cited by 19
Du, J., Jin, L., Wang, S., Hu, X., Yu, J., Yu, J., Huo, Q., Wu, N., Liu, X., Yang, Y., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag171 · Cited by 15
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
